NCT05652946

Brief Summary

A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation. We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 17, 2022

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2025

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

2 years

First QC Date

November 14, 2022

Last Update Submit

December 7, 2022

Conditions

Keywords

Advanced Rehabilitation TechnologyTherapeutic DeviceRobotic Rehabilitation ResearchHealth EconomicsFunctional Outcomes

Outcome Measures

Primary Outcomes (1)

  • Neuro-QOL

    Neuro-QOL battery: Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and Activities, Positive Affect and Well-Being

    Through study completion, an average of 2 years

Secondary Outcomes (16)

  • Length of stay/# of visits

    Through study completion, an average of 2 years

  • Total cost of care (TCOC)

    Through study completion, an average of 2 years

  • Cost of caregiver burden

    Through study completion, an average of 2 years

  • Discharge disposition

    Through study completion, an average of 2 years

  • Return to work/school/volunteer

    Through study completion, an average of 2 years

  • +11 more secondary outcomes

Other Outcomes (1)

  • Goal attainment scale (GAS)

    Through study completion, an average of 2 years

Study Arms (2)

Inpatient Rehabilitation with ART

EXPERIMENTAL

Inpatient rehabilitation with advanced rehabilitation technology

Device: Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics

Inpatient Rehabilitation without ART

ACTIVE COMPARATOR

Inpatient rehabilitation without advanced rehabilitation technology

Other: Standard inpatient rehabilitation therapy

Interventions

Participants to receive at least 5 sessions with advanced rehabilitation technology including at least one, or multiple, of the following devices: Amadeo, Diego, Myro, Arm Motus EMU, Pelma Motus, Tigo, Balo, EKSO NR. Sessions are 45 (+/- 5) minutes

Inpatient Rehabilitation with ART

Standard inpatient rehabilitation therapy without advanced rehabilitation technology

Inpatient Rehabilitation without ART

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently admitted for inpatient rehabilitation at Rehabilitation Hospital Overland Park with neurological diagnosis.
  • At least 18 years of age.
  • Predicted length of stay to be at least 7 days.
  • Able to tolerate upright sitting without orthostatic hypotension for upper extremity, cycling, and sitting balance devices AND/OR able to tolerate upright standing for at least 15 minutes without orthostatic hypotension for walking and standing balance devices.
  • Able to fit into at least one device.
  • Screened and cleared by a physician.
  • Cognitively intact to communicate pain and/or need to stop session, and able to follow simple commands.

You may not qualify if:

  • Current or history of other medical conditions that could affect the outcome measures.
  • Currently involved in another intervention study.
  • Any absolute contraindication listed for each device used.
  • Any pre-existing physical or medical condition that the Physiatrist determines would significantly limit a patient's ability to benefit from or continue in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Hospital of Overland Park

Overland Park, Kansas, 66207, United States

RECRUITING

Related Publications (1)

  • Spiess MR, Steenbrink F, Esquenazi A. Getting the Best Out of Advanced Rehabilitation Technology for the Lower Limbs: Minding Motor Learning Principles. PM R. 2018 Sep;10(9 Suppl 2):S165-S173. doi: 10.1016/j.pmrj.2018.06.007.

    PMID: 30269803BACKGROUND

MeSH Terms

Conditions

Nervous System Diseases

Study Officials

  • Brett Schoen, MD

    Rehabilitation Hospital of Overland Park

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeana R Young, AAS

CONTACT

Leslie R VanHiel, DScPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Masked/blinded outpatient therapists will perform outcome assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One group receives inpatient rehabilitation with advanced rehabilitation technology and one group receives inpatient traditional rehabilitation without advanced rehabilitation technology.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

November 14, 2022

First Posted

December 15, 2022

Study Start

October 17, 2022

Primary Completion

October 17, 2024

Study Completion

January 17, 2025

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations